Join to View Full Profile
1725 W Harrison StSte 1010Chicago, IL 60612
Phone+1 301-980-6787
Dr. Mulshine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Mulshine is an oncologist based in Chicago, IL, with a focus on thoracic, general medical, and endocrine oncology. He completed his internal medicine residency at Cleveland Clinic Foundation in 1980 and graduated from Loyola University Chicago Stritch School of Medicine in 1977. Dr. Mulshine completed Internal Medicine training at the Cleveland Clinic in 1980 and Medical Oncology training at the National Cancer Institute in 1982. He remand at Bethesda on the research faculty until 2005. He then moved to Rush University as Associate Provost and Vice President of Research and stayed on at Rush to the present time in a number of capacities.
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1980
Loyola University Chicago Stritch School of MedicineClass of 1977
Certifications & Licensure
IL State Medical License 2005 - 2026
MD State Medical License 1980 - 2007
OH State Medical License 1978 - 1982
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer.Harriet L Lancaster, Anna N H Walstra, Kyle Myers, Ricardo S Avila, Jan Willem C Gratama
European Journal of Cancer. 2025-05-02 - AI integrations with lung cancer screening: Considerations in developing AI in a public health setting.James L Mulshine, Ricardo S Avila, Mario Silva, Carolyn Aldige, Torsten Blum
European Journal of Cancer. 2025-05-02 - CT acquisition protocols for lung cancer screening-current landscape and the urgent need for consistency.Mathis Franz Georg Konrad, Emily Nischwitz, Aad van der Lugt, Gudrun Zahlmann, Viktoria Palm
Insights Into Imaging. 2025-03-26
Press Mentions
AI Integration in Global Programs of CT Screening for Lung Cancer and Other Tobacco-Related IllnessesApril 23rd, 2025- Experts Urge Improved Patient Engagement to Increase CT Lung Screening RatesDecember 6th, 2021
- NSCLC Survival Improving in U.S.; Older Patients UndertreatedOctober 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
